{"id":"doi:10.1097/mol.0000000000000114","kind":"review","title":"PCSK9 and LDLR degradation","authors":["Thomas A. Lagace"],"author_count":1,"year":2014,"published":"2014-08-08","venue":"Current Opinion in Lipidology","cited_by":372,"doi":"10.1097/mol.0000000000000114","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1097/mol.0000000000000114","archive_url":"https://space-kitty.com/papers/doi:10.1097/mol.0000000000000114","updated":null,"pmid":"25110901","pmcid":null,"openalex_id":"W2036304437","pdf_url":null,"abstract":null,"abstract_license":null,"license":"cc-by-nc-nd","is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Lipoproteins and Cardiovascular Health"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"cardiovascular-innovation","name":"Cardiovascular Therapeutics","domain_slug":"medicine"}],"cited_in_dossiers":[]}